SECONDARY HYPERTHYROIDISM

This adverse event was reported 97 times

These drugs are most commonly taken by patients reporting SECONDARY HYPERTHYROIDISM:

# Drug Count
0 ESOMEPRAZOLE MAGNESIUM 29
1 OMEPRAZOLE MAGNESIUM 29
2 FUROSEMIDE 16
3 LANSOPRAZOLE 16
4 AMLODIPINE 14
5 ASPIRIN 13
6 ASPIRIN 325 MG 13
7 ASPIRIN 81 MG 13
8 LISINOPRIL 13
9 PANTOPRAZOLE SODIUM 13
See all common drugs associated with SECONDARY HYPERTHYROIDISM

SECONDARY HYPERTHYROIDISM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DOXERCALCIFEROL 1 0.0060
1 DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE 2 0.0038
2 FAMOTITINE 4 0.0014
3 ESTRADIOL VALERATE 1 0.0013
4 CEFPROZIL 1 0.0013
5 DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE 1 0.0012
6 TERCONAZOLE 1 0.0012
7 PROPYLTHIOURACIL 2 0.0010
8 CALCIUM CARBONATE, SIMETHICONE 5 0.0009
9 PSYLLIUM HUSK 1 0.0007
See all drugs enriched for association with SECONDARY HYPERTHYROIDISM

SECONDARY HYPERTHYROIDISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phosphate Binder [EPC] 2 0.0007
1 Vitamin D3 Analog [EPC] 11 0.0005
2 Bismuth [EPC] 3 0.0005
3 alpha-Hydroxy Acid [EPC] 1 0.0005
4 Thyroid Hormone Synthesis Inhibitor [EPC] 3 0.0003
5 Vitamin D2 Analog [EPC] 2 0.0003
6 Provitamin D2 Compound [EPC] 8 0.0003
7 Sulfonamide Antibacterial [EPC] 1 0.0003
8 Cephalosporin Antibacterial [EPC] 2 0.0002
9 Alkaloid [EPC] 5 0.0002
See all drug classes enriched for association with SECONDARY HYPERTHYROIDISM